Name: Cannabichromene
Brand: Alomone Labs
SKU: C-315

Overview

Cat #: C-315

Alternative Name Cannabichrome, Pentylcannabichromene, CBC

Source Synthetic

MW: 314.5

Purity: >98%

Form Oily material.

Effective concentration 10 nM - 100 µM.

Structure

Please note, this product is available for sale in Israel only.

Chemical name 2-methyl-2-(4-methylpent-3-enyl)-7-pentylchromen-5-ol.

Molecular formula C₂₁H₃₀O₂.

CAS No.: 20675-51-8

Activity CBC is an activator of TRPA1 with an EC₅₀ of 90 nM and a blocker of TRPM8 with an IC₅₀ of 40 µM¹.

References-Activity

De Petrocellis, L. et al. (2001) Br. J. Pharmacol. 163, 1479.

Shipping and storage Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.

Solubility Up 100 mM in DMSO. Centrifuge all product preparations before use (5,000 x g for 1 min).

Storage of solutions Up to four weeks at 4°C or three months at -20°C.

Our bioassay

Alomone Labs Cannabichromene activates TRPA1 channels expressed in HEK-293 cells.
Dose-response curve for the activation of human TRPA1 expressing HEK-293 cells loaded with Calcium 5 dye for changes in intracellular Ca²⁺ measurements. Calcium signal was apparent with 5 µM Cannabichromene (#C-315).

References - Scientific background

De Petrocellis, L. et al. (2001) Br. J. Pharmacol. 163, 1479.
Romano, B. et al. (2013) Br. J. Pharmacol. 169, 213.
Russo, E.B. (2011) Br. J. Pharmacol. 163, 1344.

Scientific background

Cannabichromene (CBC) is a member of the cannabinoids, compounds derived from a diterpene structure origin of the marijuana plant Cannabis sativa, and particularly abundant in freshly harvested dry-type Cannabis material. These compounds have been used for over a 1000 years as medicinal agents for the relief of pain, as well as for recreational purposes¹.

CBC is a major non-psychotropic phytocannabinoid that inhibits endocannabinoid inactivation and activates the transient receptor potential ankyrin-1 (TRPA1) channels and enzymes of the endocannabinoid system. In addition, it also acts as a TRPM8 antagonist.

CBC selectively reduces inflammation-induced hypermotility in vivo independently from cannabinoid receptors or TRPA1^1,2.

Several studies have demonstrated that CBC exerts antimicrobial, anti-inflammatory, analgesic and antidepressant-like activity in rodents and has the ability to normalize in vivo intestinal motility in an experimental model of intestinal inflammation³.

Cannabichromene potency tested induced TRPA1-mediated Ca²⁺ elevation showed efficacy of EC₅₀ of 90 nM¹.

Target TRPA1, TRPM8 channels, Cannabinoid receptor 1

Cannabichromene (#C-315) is a highly pure, synthetic, and biologically active compound.

Certificate of Analysis SDS

For research purposes only, not for human use

Last Update: 02/01/2024

Navigation

Order Summary

Cannabichromene

Overview

Applications

Citations

Specifications

Scientific Background

Need Help With This Product?